Skip to main content

Segura Dávila, Karen

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Segura Dávila, Karen

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

Related professionals

Imanol Otaegui Irurueta

Imanol Otaegui Irurueta

Predoctoral researcher
Cardiovascular Diseases
Read more
José Raul Herance Camacho

José Raul Herance Camacho

Head of group
Molecular Imaging and Therapy
Read more
Cristina  Cea  Arestín

Cristina Cea Arestín

Predoctoral researcher
Kidney Physiopathology
Read more
David Berlana Martín

David Berlana Martín

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.